highly significantP <0.01
Analysis of efficacy variables showed a highly significant reduction ( P <0.01) in the VAS pain score and the WOMAC subscores for physical function and stiffness in the diacerein group.
Analysis of efficacy variables showed a highly significant reduction ( P <0.01) in the VAS pain score and the WOMAC subscores for physical function and stiffness in the diacerein group.